Marksans Pharma Limited

MARKSANS | NSE

190.21

INR

-3.04

-1.57%

MARKSANS | NSE

Loading StockChartView...

About Marksans Pharma Limited

Sector

Healthcare

Industry

Drug Manufacturers-General

Earnings date

31/03/2024

As of date

24/04/2026

Close

190.21

Open

195.00

High

195.00

Low

187.00

Marksans Pharma Limited together with its subsidiaries engages in the research and development manufacturing marketing distribution and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics benign prostatic hyperplasia antidiabetic epilepsy anti-inflammatory hyperparathyroidism diabetes antacids neurology cardiovascular hormonal oncology gastroenterology antidiabetic pain management gynecology antibiotic antifungal antiulceratives vitamins dermatology cephalosporins injectables anti-allergy antibacterial and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai India.

View Less

MARKSANS | NSE

Risk

44.6

-0.42

55/100

Hold

What's Working

Positive Momentum

Low Debt to Equity (< 0.25)

Low Debt to Asset (< 0.2)

Strong Revenue Growth (> 10%)

What's not Working

Weakness based on declining price with high volume

Smallcap (300M - 2B USD)

High Market Beta (> 0.8)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

Loading RiskMeterView...

10 days

43.1%

1 month

44.6%

3 months

44.0%

6 months

36.6%

Returns

Loading ReturnMeterView...

Fundamental Ratios

PE

38.34

Fwd. PE

Price to book

6.21

Debt to equity

0.12

Debt to assets

0.09

Ent. to EBITDA

24.31

Ent. to rev.

5.69

PEG

Other Fundamentals

EBITDA

4.89B

MarketCap

86.61B

MarketCap(USD)

903.00M

Div. yield

0.21

Op. margin

18.29

Erngs. growth

28.90

Rev. growth

18.10

Ret. on equity

16.35

Short ratio

Short perc.

SMAs: Stock Price Trends

Loading MovingAverageView...

Range10D

24.18

Range1M

40.68

Range3M

40.68

Volume Averages

Loading VolumeAverageView...

Rel. volume

1.62

Price X volume

281.24M

Name	Ticker	Industry	Close	Marketcap	Day Return	PE Ratio	Debt to Equity

Garware Hi-Tech Films Limited	GRWRHITECH	Specialty Chemicals	4035.9	92.99B	-3.81%	37.43	0.97%
Prime Focus Limited	PFOCUS	Entertainment	306.9	92.20B	-5.28%	n/a	941.72%
Clean Science and Technology Ltd	CLEAN	Specialty Chemicals	816.75	85.93B	2.00%	67.65	0.17%
Sanofi India Limited	SANOFI	Drug Manufacturers-General	3427.6	78.94B	-0.51%	29.45	3.23%
Alkyl Amines Chemicals Limited	ALKYLAMINE	Specialty Chemicals	1475.6	75.52B	-3.24%	77.08	0.25%
Saregama India Limited	SAREGAMA	Entertainment	346.75	68.14B	-0.47%	54.06	0.37%
Galaxy Surfactants Limited	GALAXYSURF	Specialty Chemicals	1764.5	62.71B	-2.02%	34.36	8.60%
Sudarshan Chemical Industries Limited	SUDARSCHEM	Specialty Chemicals	869.55	60.20B	-3.52%	60.10	40.65%
Kingfa Science & Technology (India) Limited	KINGFA	Specialty Chemicals	4920.4	59.59B	0.06%	30.96	5.53%
Gulf Oil Lubricants India Limited	GULFOILLUB	Specialty Chemicals	969.5	48.26B	-0.26%	19.73	28.21%

Name	Ticker	Industry	Close	Marketcap	Day Return	PE Ratio	Debt to Equity

Vertoz Advertising Limited	VERTOZ	Advertising Agencies	50.36	44.18B	-2.59%	48.67	10.74%
"SAI SILKS (KALAMANDIR) LIMITED "	KALAMANDIR	Apparel Retail	105.44	15.54B	-1.25%	28.83	43.67%
Signpost India Limited	SIGNPOST	Advertising Agencies	261.58	15.33B	-2.64%	30.54	80.30%
V2 Retail Limited	V2RETAIL	Apparel Retail	203.06	7.24B	-2.11%	120.49	191.28%
Bhagyanagar India Ltd	BHAGYANGR	Copper	219.34	7.09B	1.49%	36.36	52.08%
Madhav Copper Limited	MCL	Copper	59	1.63B	-1.55%	82.22	32.14%
Cubex Tubings Limited	CUBEXTUB	Copper	89.31	1.30B	-1.13%	35.85	21.78%
Touchwood Entertainment Limited	TOUCHWOOD	Advertising Agencies	75.31	839.62M	0.39%	50.06	4.88%
Sagardeep Alloys Limited	SAGARDEEP	Copper	23.58	409.35M	-2.16%	58.62	43.14%
Heads UP Ventures Limited	HEADSUP	Apparel Retail	7.29	159.72M	0.00%	n/a	0.00%

Parameter	Company	Industry	Indicator
Enterprise to EBITDA	24.31	25.64	Par
Ent. to Revenue	5.69	6.59	Par
PE Ratio	38.34	41.48	Par
Price to Book	6.21	10.46	Cheaper
Dividend Yield	0.21	0.96	Poor
Std. Deviation (3M)	44.00	41.14	Par
Debt to Equity	0.12	0.14	Par
Debt to Assets	0.09	0.08	Par
Market Cap	86.61B	186.70B	Emerging

Unlock Your Investing Potential

Join over 2,000+ Investors

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Marksans Pharma Limited

190.21

MARKSANS | NSE

About Marksans Pharma Limited

Sector

Industry

Earnings date

As of date

Close

Open

High

Low

MARKSANS | NSE

Risk

Sharpe

Luna's Score

Recommendation

Luna says (MARKSANS | NSE)

What's Working

What's not Working

Volatility Signals

Risk Meter

Returns

Fundamental Ratios

PE

Fwd. PE

Price to book

Debt to equity

Debt to assets

Ent. to EBITDA

Ent. to rev.

PEG

Other Fundamentals

EBITDA

MarketCap

MarketCap(USD)

Div. yield

Op. margin

Erngs. growth

Rev. growth

Ret. on equity

Short ratio

Short perc.

Market Sentiment (SMA and Price signals)

SMAs: Stock Price Trends

Volumes: Market Activity

Volume Averages

Peers

Diversifiers

Industry Comparison

Unlock Your Investing Potential

Join over 2,000+ Investors

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Discover Top-Performing Industries

Explore Stocks for Short and Long-Term Gains